CLOV
Clover Health Investments, Corp · Healthcare · Healthcare Plans
$4.46
-2.62% today · -3.04% 1W
Oct 30 close or latest
Next report
Nov 4
Wed · after the close · in 2 days
EPS estimate
$0.01
$0.01 to $0.01 · 1 analysts
Revenue estimate
$738.2M
$727.6M to $744.4M
Track record
4/8 beats
last 8 reports · moved ±11.2% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days | Guidance |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 AMC | 2Q2026 | $0.05 | $0.07 | +$0.02 beat | $743.2M | +12.6% +12.7 vs SPY | +18.1% | +9.7% | — |
| May 6, 2026 AMC | 1Q2026 | $0.07 | $0.07 | +$0.00 in line | $749.2M | +5.2% +5.5 vs SPY | +3.0% | +32.5% | — |
| Feb 25, 2026 AMC | 4Q2025 | −$0.05 | −$0.05 | +$0.00 in line | $487.7M | +2.9% +3.4 vs SPY | +1.0% | +3.4% | — |
| Nov 4, 2025 AMC | 3Q2025 | $0.02 | $0.00 | −$0.02 miss | $496.6M | -15.8% -16.1 vs SPY | -19.9% | -27.6% | — |
| Aug 5, 2025 AMC | $0.03 | $0.03 | $0.00 in line | — | -20.7% -21.5 vs SPY | -18.2% | -12.3% | — | |
| May 6, 2025 AMC | −$0.07 | $0.05 | +$0.12 beat | — | +12.5% +12.1 vs SPY | +2.8% | +1.5% | — | |
| Feb 27, 2025 AMC | −$0.06 | −$0.05 | +$0.01 beat | — | -4.1% -5.7 vs SPY | -3.7% | -11.3% | — | |
| Nov 6, 2024 AMC | −$0.03 | −$0.02 | +$0.01 beat | — | -15.6% -16.4 vs SPY | -10.6% | -27.4% | — | |
| Aug 5, 2024 AMC | −$0.04 | $0.02 | +$0.06 beat | — | -2.7% -3.6 vs SPY | +6.4% | -0.5% | — | |
| May 7, 2024 AMC | −$0.08 | −$0.05 | +$0.03 beat | — | +17.7% +17.7 vs SPY | +19.5% | +37.8% | — | |
| Mar 12, 2024 AMC | −$0.14 | −$0.11 | +$0.03 (+21.4%) beat | — | +5.0% +5.1 vs SPY | +10.7% | +7.0% | — | |
| Nov 6, 2023 AMC | −$0.11 | −$0.08 | +$0.03 (+27.3%) beat | — | -18.1% -18.4 vs SPY | -15.3% | -20.4% | — | |
| Aug 8, 2023 AMC | −$0.13 | −$0.05 | +$0.08 (+61.5%) beat | — | +4.5% +5.2 vs SPY | +10.5% | +6.8% | — | |
| May 9, 2023 AMC | −$0.17 | −$0.14 | +$0.03 (+17.6%) beat | — | -1.3% -1.8 vs SPY | -0.4% | +8.6% | — | |
| Feb 28, 2023 BMO | −$0.24 | −$0.22 | +$0.02 (+8.3%) beat | — | +14.8% +15.2 vs SPY | +8.7% | -15.7% | — | |
| Nov 7, 2022 AMC | −$0.24 | −$0.16 | +$0.08 (+33.3%) beat | — | -5.2% -5.7 vs SPY | +0.7% | +8.8% | — | |
| Aug 8, 2022 AMC | −$0.20 | −$0.22 | −$0.02 (−10.0%) miss | — | -17.9% -17.5 vs SPY | -14.1% | -4.4% | — | |
| May 9, 2022 AMC | −$0.27 | −$0.16 | +$0.11 (+40.7%) beat | — | -1.7% -1.9 vs SPY | +14.5% | +7.5% | — | |
| Feb 28, 2022 AMC | −$0.26 | −$0.44 | −$0.18 (−69.2%) miss | — | -0.4% +1.1 vs SPY | +1.1% | -4.4% | — | |
| Nov 9, 2021 BMO | −$0.23 | −$0.08 | +$0.15 (+65.2%) beat | — | -6.2% -5.9 vs SPY | -3.0% | -5.8% | — | |
| Aug 11, 2021 AMC | −$0.14 | −$0.78 | −$0.64 (<−100%) miss | — | — | — | — | — | |
| May 17, 2021 AMC | −$0.10 | −$0.13 | −$0.03 (−30.0%) miss | — | — | — | — | — | |
| Apr 7, 2021 BMO | −$0.46 | −$2.95 | −$2.49 (<−100%) miss | — | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $0.01 (1) | $0.01 – $0.01 | +203% | ▲0 ▼1 | $738.2M | +49% | |
| Next quarter · Dec 31, 2026 | −$0.02 (1) | −$0.02 – −$0.02 | +56% | -50.0% | ▲0 ▼1 | $723.5M | +48% |
| Current year · Dec 31, 2026 | $0.14 (1) | $0.14 – $0.14 | +259% | +55.6% | ▲0 ▼1 | $3.0B | +54% |
| Next year · Dec 31, 2027 | $0.15 (1) | $0.15 – $0.15 | +7% | +50.0% | ▲0 ▼1 | $3.5B | +19% |
Consensus as of Oct 20, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.